Thu, March 21, 2024

Etzer Darout Maintained (BNTX) at Buy with Decreased Target to $123 on, Mar 21st, 2024

Etzer Darout of BMO Capital, Maintained "BioNTech SE" (BNTX) at Buy with Decreased Target from $127 to $123 on, Mar 21st, 2024.

Etzer has made no other calls on BNTX in the last 4 months.



There are 3 other peers that have a rating on BNTX. Out of the 3 peers that are also analyzing BNTX, 1 agrees with Etzer's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $100 on, Wednesday, February 28th, 2024


These are the ratings of the 2 analyists that currently disagree with Etzer


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $107 on, Tuesday, January 23rd, 2024
  • Jessica Fye of "JP Morgan" Downgraded from Hold to Sell and Decreased Target to $99 on, Friday, December 1st, 2023